( November 4, 2025, 8:41 AM EST) -- CAMDEN, N.J. — Plaintiffs in the valsartan, losartan and irbesartan hypertension drugs multidistrict litigation pending in a New Jersey federal court moved for a preliminary approval of a $2 million settlement agreement reached with certain defendants to end economic loss claims....